Tenax Therapeutics TENX
NASDAQ TENX
$1.98 +0.05 (+2.59%)
At close: Oct 2, 2026 · 4:00 PM EDT

Tenax Therapeutics (TENX) Cash & Equivalents (2010 - 2026)

Updated

Tenax Therapeutics' Cash & Equivalents came in at $117.98 million for Q2 2026, up 11.9% from $105.46 million a year earlier but down 0.7% from the prior quarter.

Analysis

Tenax Therapeutics (TENX) Cash & Equivalents (2010 - 2026) Analysis & Trends

At the end of FY2025, Tenax Therapeutics' Cash & Equivalents was $97.57 million, up 2.9% from FY2024.

  • Cash & Equivalents has increased in each of the last three years, with a five-year compound annual growth rate of 73.3% (FY2020 to FY2025).
  • Going back by year, Cash & Equivalents was $94.85 million in FY2024 (+868.7%), $9.79 million in FY2023 (+361.0%), $2.12 million in FY2022 (-62.0%) and $5.58 million in FY2021 (-10.7%).
  • The five-year range for quarterly Cash & Equivalents is $2.12 million (Q4 2022) to $118.76 million (Q1 2026).
  • Year-over-year, Cash & Equivalents has increased for four consecutive quarters, with growth averaging 351.6% over the last seven quarters.
  • The fastest year-over-year change in Cash & Equivalents over five years came in Q4 2024 (growth of 868.7%), and the weakest in Q4 2022 (a decline of 62.0%).
  • Business Quant data shows TENX's Cash & Equivalents at $118.76 million (Q1 2026), $97.57 million (Q4 2025) and $99.37 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.42 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.89 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 976.00 Mn
10 Tenax Therapeutics 89.55 Mn 89.55 Mn - 117.98 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 117.98 Mn
Mar 31, 2026 118.76 Mn
Dec 31, 2025 97.57 Mn
Sep 30, 2025 99.37 Mn
Jun 30, 2025 105.46 Mn
Mar 31, 2025 111.45 Mn
Dec 31, 2024 94.85 Mn
Sep 30, 2024 98.31 Mn
Jun 30, 2024 9.38 Mn
Mar 31, 2024 12.55 Mn
Dec 31, 2023 9.79 Mn
Sep 30, 2023 11.14 Mn
Jun 30, 2023 13.39 Mn
Mar 31, 2023 14.41 Mn
Dec 31, 2022 2.12 Mn
Sep 30, 2022 3.81 Mn
Jun 30, 2022 7.23 Mn
Mar 31, 2022 2.90 Mn
Dec 31, 2021 5.58 Mn
Sep 30, 2021 8.35 Mn
API Access

Tenax Therapeutics Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TENX&period=max&api_key=YOUR_API_KEY